Pilot data from AT (n=157) was analysed with a conditional logit model and priors of the pilot design were updated ... and the study was supported by the Trials@Home Patient Expert Panel (PEP) members ...
Shares of Engene Holdings Inc. (NASDAQ:ENGN) were trading at $10.34, up $4.33, or 72%, on word of additional preliminary data from the pivotal cohort of its ongoing phase II Legend trial testing ...
The Atlanta Fed’s closely watched GDPNow model shows the U.S. economy surging ahead at a 3.9% annualized growth rate for the third quarter of the year, a strong reading that conflicts with some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback